VIR BIOTECHNOLOGY INC (VIR)

US92764N1028 - Common Stock

12.48  +4.59 (+58.17%)

After market: 12.75 +0.27 (+2.16%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.095B
1,333.77%
1.616B
47.51%
86.18M
-94.67%
75.934M
-11.89%
30.66M
-59.62%
38.294M
24.90%
75.927M
98.27%
327.69M
331.59%
726.44M
121.69%
745.25M
2.59%
EBITDA
YoY % growth
426.6M
246.30%
839.9M
96.88%
-664.854M
-179.16%
-600.17M
9.73%
-616.732M
-2.76%
-676.146M
-9.63%
-613.272M
9.30%
-308.05M
49.77%
480.56M
256.00%
N/A
EBIT
YoY % growth
420.8M
241.68%
833.1M
97.98%
-684.305M
-182.14%
-613.855M
10.30%
-636.371M
-3.67%
-673.615M
-5.85%
-630.442M
6.41%
-549.911M
12.77%
-98.509M
82.09%
-340.067M
-245.22%
Operating Margin
38.42%51.56%-794.04%-808.41%-2,075.57%-1,759.06%-830.33%-167.81%-13.56%-45.63%
EPS
YoY % growth
3.88
256.45%
3.81
-1.80%
-4.59
-220.47%
-3.97
13.59%
-3.85
3.04%
-3.87
-0.51%
-3.31
14.29%
-2.65
19.97%
2.59
197.52%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.88
-2.47%
-0.80
-66.28%
-0.82
19.30%
-0.85
45.19%
-0.94
-7.09%
Revenue
Q2Q % growth
8.221M
-51.03%
18.396M
-67.37%
14.76M
380.00%
11.09M
365.97%
13.736M
67.08%
EBITDA
Q2Q % growth
-130.593M
-9.22%
-154.732M
-104.64%
-165.64M
-34.04%
-176.548M
14.68%
-177.861M
-36.19%
EBIT
Q2Q % growth
-139.801M
-0.56%
-125.404M
-56.50%
-126.336M
4.55%
-124.314M
43.13%
-142.713M
-2.08%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-1.56
-27.87%
-1.06-0.50-46.72%
Q2 2024
Q2Q % growth
-1.02
29.66%
-0.90-0.12-12.81%
Q1 2024
Q2Q % growth
-0.48
54.72%
-1.060.5854.80%
Q4 2023
Q2Q % growth
-0.86
-13.16%
-1.020.1615.51%
Q3 2023
Q2Q % growth
-1.22
-193.85%
-1.220.00-0.20%
Q2 2023
Q2Q % growth
-1.45
-150.00%
-1.22-0.23-19.31%
Q1 2023
Q2Q % growth
-1.06
-127.53%
-0.88-0.18-20.02%
Q4 2022
Q2Q % growth
-0.76
-119.39%
-0.40-0.36-90.50%
Q3 2022
Q2Q % growth
1.30
58.54%
-0.221.52704.29%
Q2 2022
Q2Q % growth
-0.58
-226.09%
0.11-0.69-648.22%
Q1 2022
Q2Q % growth
3.85
391.67%
3.820.030.84%
Q4 2021
Q2Q % growth
3.92
572.29%
3.070.8527.67%
Q3 2021
Q2Q % growth
0.82
222.39%
0.020.803,451.54%
Q2 2021
Q2Q % growth
0.46
270.37%
-0.480.94195.45%
Q1 2021
Q2Q % growth
-1.32
-85.92%
-0.21-1.11-513.99%
Q4 2020
Q2Q % growth
-0.83
-20.29%
-0.71-0.12-16.97%
Q3 2020
Q2Q % growth
-0.67
85.43%
-0.60-0.07-11.05%
Q2 2020
Q2Q % growth
-0.27 -0.620.3556.66%
Q1 2020
Q2Q % growth
-0.71 -0.53-0.18-33.19%
Q4 2019
Q2Q % growth
-0.69 -0.67-0.02-2.35%
Q3 2019
Q2Q % growth
-4.60 -3.74-0.86-22.84%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.38M
-9.81%
5.565M-3.185M-57.23%
Q2 2024
Q2Q % growth
3.075M
-19.02%
7.571M-4.496M-59.38%
Q1 2024
Q2Q % growth
56.376M
-10.45%
11.829M44.547M376.59%
Q4 2023
Q2Q % growth
16.787M
-66.02%
12.276M4.511M36.75%
Q3 2023
Q2Q % growth
2.639M
-99.30%
10.339M-7.7M-74.48%
Q2 2023
Q2Q % growth
3.797M
109.35%
26.145M-22.348M-85.48%
Q1 2023
Q2Q % growth
62.957M
-94.89%
50.6M12.357M24.42%
Q4 2022
Q2Q % growth
49.4M
-93.92%
98.278M-48.878M-49.73%
Q3 2022
Q2Q % growth
374.6M
261.58%
173.16M201.44M116.33%
Q2 2022
Q2Q % growth
-40.6M
-122.92%
217.53M-258.13M-118.66%
Q1 2022
Q2Q % growth
1.233B
61,525.00%
845.34M387.16M45.80%
Q4 2021
Q2Q % growth
812.7M
47,705.88%
629.13M183.57M29.18%
Q3 2021
Q2Q % growth
103.6M
5,352.63%
139.63M-36.03M-25.80%
Q2 2021
Q2Q % growth
177.1M
164.33%
85.409M91.691M107.36%
Q1 2021
Q2Q % growth
2M
-64.91%
99.62M-97.62M-97.99%
Q4 2020
Q2Q % growth
1.7M
70.00%
4.863M-3.163M-65.04%
Q3 2020
Q2Q % growth
1.9M
35.71%
19.195M-17.295M-90.10%
Q2 2020
Q2Q % growth
67M
3,250.00%
3.935M63.065M1,602.67%
Q1 2020
Q2Q % growth
5.7M
54.05%
2.946M2.754M93.48%
Q4 2019
Q2Q % growth
1M 2.302M-1.302M-56.56%
Q3 2019
Q2Q % growth
1.4M 3.504M-2.104M-60.05%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 12.46% 0% -15.99%
Revenue0% -24.1% 0% 6.01%